Hersey P - Search Results

1

Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition.

Madorsky Rowdo FP, Barón A, Gallagher SJ, Hersey P, Emran AA, Von Euw EM, Barrio MM, Mordoh J. Madorsky Rowdo FP, et al. Among authors: hersey p. Int J Oncol. 2020 Jun;56(6):1429-1441. doi: 10.3892/ijo.2020.5031. Epub 2020 Mar 30. Int J Oncol. 2020. PMID: 32236593 Free PMC article.

2

A Combination of Epigenetic BET and CDK9 Inhibitors for Treatment of Human Melanoma.

Emran AA, Tseng HY, Gunatilake D, Cook SJ, Ahmed F, Wang S, Hersey P, Gallagher SJ, Tiffen JC. Emran AA, et al. Among authors: hersey p. J Invest Dermatol. 2021 Sep;141(9):2238-2249.e12. doi: 10.1016/j.jid.2020.12.038. Epub 2021 Mar 26. J Invest Dermatol. 2021. PMID: 33781756 Free article.

3

Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitors.

Lai F, Jin L, Gallagher S, Mijatov B, Zhang XD, Hersey P. Lai F, et al. Among authors: hersey p. Adv Pharmacol. 2012;65:27-43. doi: 10.1016/B978-0-12-397927-8.00002-6. Adv Pharmacol. 2012. PMID: 22959022 Review.

4

The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance.

Wroblewski D, Mijatov B, Mohana-Kumaran N, Lai F, Gallagher SJ, Haass NK, Zhang XD, Hersey P. Wroblewski D, et al. Among authors: hersey p. Carcinogenesis. 2013 Feb;34(2):237-47. doi: 10.1093/carcin/bgs330. Epub 2012 Oct 20. Carcinogenesis. 2013. PMID: 23087082

5

A focus on PD-L1 in human melanoma.

Hersey P, Gallagher S. Hersey P, et al. Clin Cancer Res. 2013 Feb 1;19(3):514-6. doi: 10.1158/1078-0432.CCR-12-3312. Epub 2012 Dec 18. Clin Cancer Res. 2013. PMID: 23251000

6

Intralesional immunotherapy for melanoma.

Hersey P, Gallagher S. Hersey P, et al. J Surg Oncol. 2014 Mar;109(4):320-6. doi: 10.1002/jso.23494. Epub 2013 Dec 3. J Surg Oncol. 2014. PMID: 24301265 Review.

7

EZH2: an emerging role in melanoma biology and strategies for targeted therapy.

Tiffen J, Gallagher SJ, Hersey P. Tiffen J, et al. Among authors: hersey p. Pigment Cell Melanoma Res. 2015 Jan;28(1):21-30. doi: 10.1111/pcmr.12280. Epub 2014 Jun 27. Pigment Cell Melanoma Res. 2015. PMID: 24912396 Review.

8

Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.

Gowrishankar K, Gunatilake D, Gallagher SJ, Tiffen J, Rizos H, Hersey P. Gowrishankar K, et al. Among authors: hersey p. PLoS One. 2015 Apr 6;10(4):e0123410. doi: 10.1371/journal.pone.0123410. eCollection 2015. PLoS One. 2015. PMID: 25844720 Free PMC article.

9

Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma.

Tiffen J, Wilson S, Gallagher SJ, Hersey P, Filipp FV. Tiffen J, et al. Among authors: hersey p. Neoplasia. 2016 Feb;18(2):121-32. doi: 10.1016/j.neo.2016.01.003. Neoplasia. 2016. PMID: 26936398 Free PMC article.

10

EZH2 as a mediator of treatment resistance in melanoma.

Tiffen JC, Gallagher SJ, Tseng HY, Filipp FV, Fazekas de St. Groth B, Hersey P. Tiffen JC, et al. Among authors: hersey p. Pigment Cell Melanoma Res. 2016 Sep;29(5):500-7. doi: 10.1111/pcmr.12481. Epub 2016 May 25. Pigment Cell Melanoma Res. 2016. PMID: 27063195 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters